Seasonal influenza A viruses (IAV) originate from pandemic IAV and have undergone
changes in antigenic structure, including addition of glycans to the hemagglutinin (HA) …

Influenza is an infectious disease and can lead to life-threatening complications like pneumonia.
The disease is caused by three types of RNA viruses called influenza types A, B and C, …

Avian influenza viruses (AIVs) circulate globally, spilling over into domestic poultry and
causing zoonotic infections in humans. Fortunately, AIVs are not yet capable of causing …

Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection
with the most severe disease in the young and elderly. Non-pharmaceutical interventions …

The clinical response to influenza infection ranges from mild disease to severe pneumonia
and it remains unclear whether the inflammatory response to infection is protective or …

The neuraminidase inhibitors (NAIs) are an effective class of antiviral drugs for the treatment
of influenza A and B infections. Until recently, only a low prevalence of NAI resistance (<1%) …

Background— Evidence suggests that induction of heme oxygenase-1 (HO-1) inhibits
proliferation of vascular smooth muscle cells and intimal thickening after arterial injury, and …

Escherichia coli INS33 was isolated from the urinary tract of an infected patient. It was resistant
to ampicillin, chloramphenicol, spectinomycin, streptomycin, sulfafurazole, tetracycline …

In March 2010, an outbreak of low pathogenicity avian influenza A (H10N7) occurred on a
chicken farm in Australia. After processing clinically normal birds from the farm, 7 abattoir …

10.7554/eLife.05055.001 A complex interplay of viral, host, and ecological factors shapes
the spatio-temporal incidence and evolution of human influenza viruses. Although …